EDAP Announces Proposed Public Offering of American Depositary Shares
LYON, France, September 22, 2022 — EDAP TMS S.A. (NASDAQ:EDAP) (the “Company”), a global leader in robotic energy-based therapies, announced today that it has commenced a public offering of its American Depositary Shares, or ADSs, each representing one ordinary share of the Company. The proposed offering is subject to market conditions, and there can be no assurance as to whether or when the proposed offering may be completed or as to the actual size or terms of the proposed offering.
Related news for (EDAP)
- EDAP Announces Completion of Enrollment in Phase 3 Study Evaluating Focal One HIFU Therapy for the Treatment of Deep Infiltrating Rectal Endometriosis
- EDAP Announces Preliminary Fourth Quarter Record Focal One® System Sales and Placements
- EDAP Appoints Lance Willsey, M.S., M.D. to Board of Directors
- EDAP Appoints Lance Willsey, M.S., M.D. to Board of Directors
- EDAP Announces First Quarter 2023 Financial Results